logo-loader
viewPivot Pharmaceuticals Inc.

Full interview: Pivot Pharmaceutical sign Letter of Intent for controlling interest in iAmHealth

Pivot Pharmaceuticals (CSE: PVOT-OTC-PVOTF) President Russell Starr sat down with Steve Darling from Proactive Vancouver to discuss their company that plays in the cannabis. Starr is discussing how the company has changed including their very influential leaders. 

Starr also told Proactive about their current sales in Europe and when they will be in Canada and the U.S. with a number of different lines including pets and sexual health. Starr also shares details about a new deal they just signed with iAmHealth.

Quick facts: Pivot Pharmaceuticals Inc.

Price: - -

CSE:PVOT
Market: CSE
Market Cap: -
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Bulls, Bears & Brokers: Alto Capital’s Tony Locantro on Nyrada IPO and small...

Alto Capital investment manager and stock market commentator Tony Locantro updates Proactive on this week's listing of Nyrada Inc (ASX:NYR), a spin-off of Noxopharm Ltd’s (ASX:NOX). He discusses the reasons for the spin-off, including some of the recent and expected trading patterns. Locantro...

1 week ago

2 min read